Decoy Therapeutics Inc. (DCOY) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
36/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseDCOY / S&P 10.09% / 15.20% |
LoseDCOY / S&P DCOY unavailable / 15.00% |
LoseDCOY / S&P -61.51% / 50.40% |
| 2026-Q10/3 |
LoseDCOY / S&P -16.14% / -4.33% |
LoseDCOY / S&P DCOY unavailable / 11.30% |
LoseDCOY / S&P -18.04% / 27.70% |
| 2025-Q41/3 |
LoseDCOY / S&P -82.32% / 2.65% |
LoseDCOY / S&P DCOY unavailable / 9.00% |
WinDCOY / S&P 4460.83% / 13.40% |
| 2025-Q31/3 |
LoseDCOY / S&P -72.69% / 8.12% |
LoseDCOY / S&P DCOY unavailable / 4.61% |
WinDCOY / S&P 1751.44% / 13.45% |
| 2025-Q22/3 |
WinDCOY / S&P 18.83% / 10.94% |
LoseDCOY / S&P DCOY unavailable / 4.83% |
WinDCOY / S&P 2889.34% / 10.63% |
| 2025-Q11/3 |
LoseDCOY / S&P -59.02% / -4.27% |
LoseDCOY / S&P DCOY unavailable / 4.98% |
WinDCOY / S&P 1134.47% / 10.57% |
| 2024-Q41/3 |
WinDCOY / S&P 27.78% / 2.41% |
LoseDCOY / S&P DCOY unavailable / 5.25% |
LoseDCOY / S&P -49.26% / 6.15% |
| 2024-Q30/3 |
LoseDCOY / S&P -39.50% / 5.89% |
LoseDCOY / S&P DCOY unavailable / 5.89% |
LoseDCOY / S&P -21.21% / 6.11% |
| 2024-Q20/3 |
LoseDCOY / S&P -43.76% / 4.28% |
LoseDCOY / S&P DCOY unavailable / 5.38% |
LoseDCOY / S&P -52.36% / 5.12% |
| 2024-Q11/3 |
LoseDCOY / S&P -18.62% / 10.56% |
LoseDCOY / S&P DCOY unavailable / 5.71% |
WinDCOY / S&P 46.87% / 5.59% |
| 2023-Q41/3 |
LoseDCOY / S&P -1.22% / 11.69% |
LoseDCOY / S&P DCOY unavailable / 6.81% |
WinDCOY / S&P 29.06% / 7.78% |
| 2023-Q31/3 |
LoseDCOY / S&P -55.84% / -3.27% |
LoseDCOY / S&P DCOY unavailable / 7.52% |
WinDCOY / S&P 52.18% / -5.03% |
| 2023-Q21/3 |
LoseDCOY / S&P -21.99% / 8.74% |
LoseDCOY / S&P DCOY unavailable / 9.50% |
WinDCOY / S&P 130.71% / -8.57% |
| 2023-Q12/3 |
WinDCOY / S&P 24.84% / 7.50% |
LoseDCOY / S&P -100.00% / 10.77% |
WinDCOY / S&P 74.90% / -15.69% |
| 2022-Q41/3 |
LoseDCOY / S&P -68.62% / 7.56% |
LoseDCOY / S&P -100.00% / 11.88% |
WinDCOY / S&P 223.62% / -17.99% |
| 2022-Q31/3 |
LoseDCOY / S&P -7.14% / -4.88% |
LoseDCOY / S&P -100.00% / 13.47% |
WinDCOY / S&P 512.93% / -1.41% |
| 2022-Q21/3 |
LoseDCOY / S&P -47.24% / -16.10% |
LoseDCOY / S&P -100.00% / 13.71% |
WinDCOY / S&P 2900.00% / 11.04% |
| 2022-Q11/3 |
LoseDCOY / S&P -19.76% / -4.60% |
LoseDCOY / S&P -89.36% / 15.97% |
WinDCOY / S&P 1892.31% / 42.23% |
| 2021-Q40/3 |
LoseDCOY / S&P -51.37% / 11.03% |
LoseDCOY / S&P -64.84% / 15.00% |
LoseDCOY / S&P DCOY unavailable / 96.40% |
| 2021-Q30/3 |
LoseDCOY / S&P -3.77% / 0.58% |
LoseDCOY / S&P -30.75% / 10.77% |
LoseDCOY / S&P DCOY unavailable / 69.42% |
| 2021-Q21/3 |
LoseDCOY / S&P -28.38% / 8.55% |
WinDCOY / S&P 9.50% / 6.58% |
LoseDCOY / S&P DCOY unavailable / 51.81% |
| 2021-Q12/3 |
WinDCOY / S&P 62.64% / 6.17% |
WinDCOY / S&P 36.20% / -1.06% |
LoseDCOY / S&P DCOY unavailable / 7.39% |
| 2020-Q41/3 |
LoseDCOY / S&P 7.82% / 12.15% |
WinDCOY / S&P 79.57% / -3.72% |
LoseDCOY / S&P DCOY unavailable / -33.42% |
| 2020-Q31/3 |
LoseDCOY / S&P -36.06% / 8.93% |
WinDCOY / S&P 90.63% / -2.04% |
LoseDCOY / S&P DCOY unavailable / -27.10% |
| 2020-Q22/3 |
WinDCOY / S&P 93.83% / 20.54% |
WinDCOY / S&P 103.46% / -0.46% |
LoseDCOY / S&P DCOY unavailable / -27.11% |
| 2020-Q11/3 |
LoseDCOY / S&P -81.98% / -19.60% |
WinDCOY / S&P 170.36% / 3.47% |
LoseDCOY / S&P DCOY unavailable / -14.75% |
| 2019-Q41/3 |
LoseDCOY / S&P -30.64% / 9.07% |
WinDCOY / S&P 90.27% / 5.36% |
LoseDCOY / S&P DCOY unavailable / 2.99% |
| 2019-Q31/3 |
LoseDCOY / S&P -60.58% / 1.70% |
WinDCOY / S&P 113.81% / 5.02% |
LoseDCOY / S&P DCOY unavailable / 0.21% |
| 2019-Q22/3 |
WinDCOY / S&P 43.26% / 4.30% |
WinDCOY / S&P 88.16% / 6.64% |
LoseDCOY / S&P DCOY unavailable / 8.65% |
| 2019-Q12/3 |
WinDCOY / S&P 16.97% / 13.65% |
WinDCOY / S&P 20.45% / 8.12% |
LoseDCOY / S&P DCOY unavailable / 14.29% |
| 2018-Q41/3 |
LoseDCOY / S&P -29.03% / -13.52% |
WinDCOY / S&P 20.18% / 9.05% |
LoseDCOY / S&P DCOY unavailable / 18.23% |
| 2018-Q30/3 |
LoseDCOY / S&P -50.53% / 7.71% |
LoseDCOY / S&P -8.88% / 10.21% |
LoseDCOY / S&P DCOY unavailable / 19.06% |
| 2018-Q20/3 |
LoseDCOY / S&P -81.20% / 3.43% |
LoseDCOY / S&P -24.09% / 9.03% |
LoseDCOY / S&P DCOY unavailable / 14.46% |
| 2018-Q11/3 |
WinDCOY / S&P 43.27% / -0.76% |
LoseDCOY / S&P -3.41% / 7.68% |
LoseDCOY / S&P DCOY unavailable / 12.46% |
| 2017-Q41/3 |
LoseDCOY / S&P 2.35% / 6.64% |
WinDCOY / S&P 26.11% / 7.03% |
LoseDCOY / S&P DCOY unavailable / 13.82% |
| 2017-Q31/3 |
LoseDCOY / S&P -11.43% / 4.48% |
WinDCOY / S&P 81.32% / 5.68% |
LoseDCOY / S&P DCOY unavailable / 17.57% |
| 2017-Q21/3 |
LoseDCOY / S&P -12.50% / 3.09% |
WinDCOY / S&P 1209.89% / 4.83% |
LoseDCOY / S&P DCOY unavailable / 17.74% |
| 2017-Q10/3 |
LoseDCOY / S&P -16.67% / 6.07% |
LoseDCOY / S&P DCOY unavailable / 3.67% |
LoseDCOY / S&P DCOY unavailable / 13.32% |
| 2016-Q40/3 |
LoseDCOY / S&P -55.18% / 3.82% |
LoseDCOY / S&P DCOY unavailable / 2.09% |
LoseDCOY / S&P DCOY unavailable / 7.05% |
| 2016-Q31/3 |
WinDCOY / S&P 15.38% / 3.85% |
LoseDCOY / S&P DCOY unavailable / 0.20% |
LoseDCOY / S&P DCOY unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DCOY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.70% | 20.78% |
| Annualized return | -95.70% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DCOY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.99% | 83.14% |
| Annualized return | -84.78% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | DCOY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -77.78% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |